Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma.

Wang, Rong; Deng, Danni; Shao, Naiyuan; Xu, Yuan; Xue, Lian; Peng, Ya; Liu, Yatian; Zhi, Feng

Wang, Rong; Deng, Danni; Shao, Naiyuan; Xu, Yuan; Xue, Lian; Peng, Ya; Liu, Yatian; Zhi, Feng.

Afiliación

Wang R; Department of Neurosurgery, The First People's Hospital of Changzhou, Changzhou, Jiangsu, China.
Deng D; Modern Medical Research Center, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Shao N; Modern Medical Research Center, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Xu Y; Department of Neurosurgery, The First People's Hospital of Changzhou, Changzhou, Jiangsu, China.
Xue L; Modern Medical Research Center, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Peng Y; Modern Medical Research Center, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Liu Y; Department of Neurosurgery, The First People's Hospital of Changzhou, Changzhou, Jiangsu, China.
Zhi F; Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China.

Onco Targets Ther ; 11: 1183-1192, 2018.

Article en En | MEDLINE | ID: mdl-29535541

Palabras clave

Akt; MAPK; apoptosis; evodiamine; glioma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google